NKIRANT Trademark

Trademark Overview

On Wednesday, January 22, 2020, a trademark application was filed for NKIRANT with the United States Patent and Trademark Office. The USPTO has given the NKIRANT trademark a serial number of 88768718. The federal status of this trademark filing is ABANDONED - NO STATEMENT OF USE FILED as of Monday, August 14, 2023. This trademark is owned by Heron Therapeutics, Inc.. The NKIRANT trademark is filed in the Pharmaceutical Products category with the following description:

Anti-emetic pharmaceutical preparations; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy
nkirant

General Information

Serial Number88768718
Word MarkNKIRANT
Filing DateWednesday, January 22, 2020
Status606 - ABANDONED - NO STATEMENT OF USE FILED
Status DateMonday, August 14, 2023
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 19, 2020

Trademark Statements

Goods and ServicesAnti-emetic pharmaceutical preparations; pharmaceutical preparations for human and animal use for the treatment of pain, for gastrointestinal conditions, cancer, post-operative, chemotherapy-induced nausea and vomiting, autoimmune diseases, infectious diseases, inflammatory diseases, genetic diseases, cardiovascular diseases, orthopedic conditions, and for immunotherapy

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateSunday, January 26, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameHeron Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121
Party NameHeron Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Diego, CA 92121

Trademark Events

Event DateEvent Description
Monday, August 14, 2023ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Monday, August 14, 2023ABANDONMENT - NO USE STATEMENT FILED
Wednesday, January 11, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, January 10, 2023SOU EXTENSION 5 GRANTED
Wednesday, December 21, 2022SOU EXTENSION 5 FILED
Tuesday, January 10, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, December 21, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, June 8, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, June 6, 2022SOU EXTENSION 4 GRANTED
Monday, June 6, 2022SOU EXTENSION 4 FILED
Monday, June 6, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, December 8, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, December 6, 2021SOU EXTENSION 3 GRANTED
Monday, December 6, 2021SOU EXTENSION 3 FILED
Monday, December 6, 2021SOU TEAS EXTENSION RECEIVED
Friday, June 18, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, June 16, 2021SOU EXTENSION 2 GRANTED
Wednesday, June 16, 2021SOU EXTENSION 2 FILED
Wednesday, June 16, 2021SOU TEAS EXTENSION RECEIVED
Tuesday, December 8, 2020NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, December 4, 2020SOU EXTENSION 1 GRANTED
Friday, December 4, 2020SOU EXTENSION 1 FILED
Friday, December 4, 2020SOU TEAS EXTENSION RECEIVED
Tuesday, July 14, 2020NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, May 19, 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 19, 2020PUBLISHED FOR OPPOSITION
Wednesday, April 29, 2020NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 14, 2020APPROVED FOR PUB - PRINCIPAL REGISTER
Friday, April 10, 2020ASSIGNED TO EXAMINER
Sunday, January 26, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 25, 2020NEW APPLICATION ENTERED

Related Keywords

nkirant diseases conditions preparations pharmaceutical nausea autoimmune vomiting infectious genetic immunotherapy